Edgen Stock·Sep 25 2025, 22:19戻る
戻る
ClearPoint Neuro Shares Advance Following Positive Huntington's Disease Trial Data
Edgen Stock·Sep 25 2025, 22:19
[1] ClearPoint Neuro: Selling The Tools For Brain Therapies (NASDAQ:CLPT) | Seeking Alpha (https://seekingalpha.com/article/4826022-clea ...)[2] Here's why biotech UniQure's stock just tripled, and brought ClearPoint shares up with it (https://vertexaisearch.cloud.google.com/groun ...)[3] UniQure (QURE) Stock Jumps 248% on Huntington's Trial Results. Analysts Raise Price Targets - TipRanks (https://www.tipranks.com/news/article/uniqure ...)